DARE vs NCLH · rev $187.5K vs P/E 16, rev $4.97B
Dare Bioscience Inc (DARE) versus Norwegian Cruise Line Holdings Ltd (NCLH) — a side-by-side from cached financials, not a winner call.
Dare Bioscience Inc (DARE) is a biotechnology company listed on US.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Latest reported DARE revenue for 2026-06-30 was $187.5K. Net income was -$3.0M. Revenue was up 23.0% from 2026-03-31 to 2026-06-30. DARE currently screens at market cap $21.2M.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
DARE currently screens at market cap $21.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Not investment advice. Open the DARE and NCLH stock pages for the full models.
Not investment advice.